J.P. Morgan discloses Kangji Medical share dealings during privatization

On October 30, 2025, J.P. Morgan Securities PLC, an associate connected with the Kangji Medical Holdings Limited offeror, disclosed several dealings in Kangji Medical shares. These transactions, made for its own account, occurred during a privatization by way of a scheme of arrangement.

Two sale transactions involved "Other types of securities" (e.g., equity swaps), related to hedging Delta 1 products from unsolicited client-driven orders. One sale involved 1,000 shares for $9,008.33, with the highest price paid/received at $9.03 and the lowest at $9.01. The second sale comprised 617,500 shares for $5,551,942.00, with both the highest and lowest prices at $9.00.

Additionally, J.P. Morgan Securities PLC reported a purchase of 617,500 ordinary shares for $5,563,613.75. This purchase, with highest and lowest prices at $9.00, was attributed to client facilitation trades arising from unsolicited client-driven orders by a facilitation desk operating independently of the group's proprietary trading desk. Any resultant proprietary positions are to be flattened by the close of the morning trading session on the next trading day.